Literature DB >> 9526539

Immunological response of mice to the bovine respiratory syncytial virus fusion glycoprotein expressed in recombinant baculovirus infected insect cells.

K Walravens1, J P Matheise, I Knott, P Coppe, A Collard, C Didembourg, F Dessy, R Kettmann, J J Letesson.   

Abstract

Bovine respiratory syncytial virus (BRSV) is a major cause of respiratory disease in calves. The BRSV genome encodes two major glycoproteins, G and F, which are the major targets for the host antibody response. We have expressed the F glycoprotein in insect cells (Sf9) using a recombinant baculovirus vector. A comparison of the F protein expressed in mammalian and insect cells by SDS-PAGE showed that only part of the baculovirus-produced protein was soluble and processed like the native protein. The antigenicity of the soluble form of the F protein expressed in insect cells was identical to that of the F protein expressed in mammalian cells. Immunization with the F protein expressed in insect cells induced neutralizing antibodies in mice. This antigenic preparation adjuvanted with Quil-A produced an increased neutralizing antibody titer and induced protection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9526539     DOI: 10.1007/bf01718633

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  31 in total

1.  Purification and characterization of the respiratory syncytial virus fusion protein.

Authors:  E E Walsh; M W Brandriss; J J Schlesinger
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891

2.  Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein.

Authors:  R J Brideau; R R Walters; M A Stier; M W Wathen
Journal:  J Gen Virol       Date:  1989-10       Impact factor: 3.891

3.  Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector.

Authors:  M W Wathen; R J Brideau; D R Thomsen; B R Murphy
Journal:  J Gen Virol       Date:  1989-10       Impact factor: 3.891

4.  Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization.

Authors:  B R Murphy; A V Sotnikov; L A Lawrence; S M Banks; G A Prince
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

5.  Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

Authors:  R A Olmsted; N Elango; G A Prince; B R Murphy; P R Johnson; B Moss; R M Chanock; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.

Authors:  M Connors; A B Kulkarni; P L Collins; C Y Firestone; K L Holmes; H C Morse; B R Murphy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine.

Authors:  T J Kakuk; K Soike; R J Brideau; R M Zaya; S L Cole; J Y Zhang; E D Roberts; P A Wells; M W Wathen
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

8.  Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.

Authors:  B R Murphy; A Sotnikov; P R Paradiso; S W Hildreth; A B Jenson; R B Baggs; L Lawrence; J J Zubak; R M Chanock; J A Beeler
Journal:  Vaccine       Date:  1989-12       Impact factor: 3.641

9.  Antibody response of calves to immunoaffinity-purified bovine respiratory syncytial virus VP70 after vaccination and challenge exposure.

Authors:  L D Nelson; C L Kelling; G A Anderson
Journal:  Am J Vet Res       Date:  1992-08       Impact factor: 1.156

10.  Monoclonal antibodies protect against respiratory syncytial virus infection in mice.

Authors:  G Taylor; E J Stott; M Bew; B F Fernie; P J Cote; A P Collins; M Hughes; J Jebbett
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

View more
  2 in total

Review 1.  Insect cells as hosts for the expression of recombinant glycoproteins.

Authors:  F Altmann; E Staudacher; I B Wilson; L März
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

2.  Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.

Authors:  Leopold Kong; Neil C Sheppard; Guillaume B E Stewart-Jones; Cynthia L Robson; Hongying Chen; Xiaodong Xu; George Krashias; Camille Bonomelli; Christopher N Scanlan; Peter D Kwong; Simon A Jeffs; Ian M Jones; Quentin J Sattentau
Journal:  J Mol Biol       Date:  2010-08-25       Impact factor: 5.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.